text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nHPI, INC.\n비상장\n2007.09.14\n해외임상시험\n187\n200,000\n100.0\n75\n-\n-\n-\n200,000\n100.0\n75\n347\n-99\nImmuno MET\n비상장\n2015.08.24\n투자\n2,173\n564,428\n9.67\n5,496\n577,002\n5,965\n662\n1,141,430\n17.80\n12,123\n1,618\n-7,119\nImmunovant Sciences Ltd.\n상장\n2019.01.11\n투자\n5,609\n939,395\n0.96\n47,209\n-\n-\n-37,536\n939,395\n0.82\n9,673\n471\n-93\nNurron Pharmaceuticals, Inc\n비상장\n2021.07.19\n투자\n571\n-\n-\n-\n58,343\n571\n-\n58,343\n2.43\n571\n4,176\n-1,204\n합 계\n1,703,823\n-\n52,780\n635,345\n6,536\n-36,874\n2,339,168\n-\n22,442\n6,612\n-8,515\n']"
